Medicare Enrolled
Dr. David Weisman, M.D.
Behavioral Neurology & Neuropsychiatry Physician · Abington, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Weisman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Weisman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Weisman
Dr. David Weisman is a behavioral neurology & neuropsychiatry physician in Abington, PA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Weisman performed 80,243 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Weisman received a total of $178,789 from 67 pharmaceutical and/or device companies across 456 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Weisman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 17% volume in PA
$178,789 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗80,243
Medicare services
Top 17% in PA for behavioral neurology & neuropsychiatry physician
Not available
Unique patients (not deduplicated)
$3
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Lecanemab injection, 1 mg Administration of a 1 mg dose of lecanemab-irmb via injection. |
78,700 | $1 | $3 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
354 | $17 | $82 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
336 | $54 | $164 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
235 | $100 | $260 |
| Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | 174 | $210 | $420 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
128 | $125 | $335 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
65 | $107 | $328 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
49 | $143 | $307 |
| Psychological test administration, first 30 minutes A technician administers psychological or neuropsychological testing for the first 30 minutes. |
39 | $29 | $201 |
| Lumbar puncture for diagnostic test A procedure to remove cerebrospinal fluid from the lower back for diagnostic testing. |
30 | $114 | $336 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
30 | $142 | $491 |
| New patient office visit, complex (60-74 min) | 29 | $166 | $414 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
22 | $73 | $147 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
22 | $178 | $550 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
18 | $66 | $191 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
12 | $76 | $147 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.9% high complexity
98.1% medium
1.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$178,789
Total received (2018-2024)
Avg $25,541/year across 7 years
Top 9% in PA for behavioral neurology & neuropsychiatry physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
67
Companies
456
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$119,570
2023
$27,297
2022
$675
2021
$22,398
2020
$1,291
2019
$5,910
2018
$1,648
Payments by company (2024)
Eisai Inc.
$88,705
Lilly USA, LLC
$29,335
ARGENX US, INC.
$329
ACADIA Pharmaceuticals Inc
$151
TG Therapeutics, Inc.
$140
ABBVIE INC.
$120
GENZYME CORPORATION
$102
Roche Diagnostics Corporation
$97
Sumitomo Pharma America, Inc.
$63
Biogen, Inc.
$49
Genentech USA, Inc.
$49
Merz Pharmaceuticals, LLC
$41
AstraZeneca Pharmaceuticals LP
$41
Lundbeck LLC
$39
Teva Pharmaceuticals USA, Inc.
$36
SK Life Science, Inc.
$34
JAZZ PHARMACEUTICALS INC.
$33
HARMONY BIOSCIENCES LLC
$32
MDD US Operations, LLC
$23
Novartis Pharmaceuticals Corporation
$22
Ipsen Biopharmaceuticals, Inc
$21
CSL Behring
$19
Otsuka America Pharmaceutical, Inc.
$19
Alexion Pharmaceuticals, Inc.
$18
Neurelis, Inc.
$18
Axsome Therapeutics, Inc.
$17
Grifols USA, LLC
$17
Top 3 companies account for 99.0% of 2024 payments
All-time payments by company (2018-2024) ›
Eisai Inc.
$110,944
Lilly USA, LLC
$29,568
Biogen, Inc.
$19,314
Merck Sharp & Dohme Corporation
$5,025
Eli Lilly and Company
$3,938
F. Hoffmann-La Roche AG
$3,840
Novartis Pharmaceuticals Corporation
$986
ARGENX US, INC.
$493
ACADIA Pharmaceuticals Inc
$358
ABBVIE INC.
$309
Genentech USA, Inc.
$290
GENZYME CORPORATION
$245
JAZZ PHARMACEUTICALS INC.
$223
Akcea Therapeutics, Inc.
$216
UCB, Inc.
$181
Teva Pharmaceuticals USA, Inc.
$172
SK Life Science, Inc.
$165
AbbVie Inc.
$159
Genentech, Inc.
$153
EMD Serono, Inc.
$151
TG Therapeutics, Inc.
$140
Lundbeck LLC
$121
Mitsubishi Tanabe Pharma America, Inc.
$120
Avanir Pharmaceuticals, Inc.
$113
Sumitomo Pharma America, Inc.
$107
Roche Diagnostics Corporation
$97
CSL Behring
$78
Supernus Pharmaceuticals, Inc.
$73
Allergan Inc.
$70
Grifols USA, LLC
$69
Currax Pharmaceuticals LLC
$67
Alexion Pharmaceuticals, Inc.
$56
Sunovion Pharmaceuticals Inc.
$56
AstraZeneca Pharmaceuticals LP
$55
Boston Scientific Corporation
$55
Adamas Pharmaceuticals, Inc.
$51
US WorldMeds, LLC
$46
Merz Pharmaceuticals, LLC
$41
Janssen Research & Development, LLC
$41
Neurocrine Biosciences, Inc.
$40
Abbott Laboratories
$40
MDD US Operations, LLC
$39
Avion Pharmaceuticals
$38
PFIZER INC.
$33
HARMONY BIOSCIENCES LLC
$32
Axsome Therapeutics, Inc.
$32
Amgen Inc.
$30
Vertical Pharmaceuticals, LLC
$26
Hoffmann-La Roche Limited
$25
Ipsen Biopharmaceuticals, Inc
$21
Otsuka America Pharmaceutical, Inc.
$19
Neurelis, Inc.
$18
IMPEL PHARMACEUTICALS INC.
$17
TG THERAPEUTICS, INC.
$16
Metacel Pharmaceuticals LLC
$16
Mallinckrodt Enterprises LLC
$16
AbbVie, Inc.
$16
GE HealthCare
$15
MITSUBISHI TANABE PHARMA AMERICA, INC.
$15
EISAI INC.
$14
ARBOR PHARMACEUTICALS, INC.
$14
Amneal Pharmaceuticals LLC
$14
Biohaven Pharmaceutical Holding Company Ltd.
$13
Corium, LLC
$13
Bayer HealthCare Pharmaceuticals Inc.
$12
Impax Laboratories, Inc.
$11
Piramal Imaging Limited
$8
Top 3 companies account for 89.4% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMYVID · APTIOM · AUBAGIO · AUSTEDO · Adlarity · Aimovig · Auvelity · BELSOMRA · BOTOX · BRIUMVI · Betaseron · Briviact · CONTRAVE · COPAXONE · DUOPA · Dhivy · Duopa · Dysport · EPIDIOLEX · Elecsys Troponin T Gen 5 STAT · FABRAZYME · FABRY-DISEASE · Fintepla · Fycompa · GILENYA · GOCOVRI · Gamunex-C · Gocovri · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · KESIMPTA · KISUNLA · LEMTRADA · LORZONE · Leqembi · MAYZENT · MYOBLOC · Mavenclad · NEURACEQ · NORTHERA · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · OSMOLEX ER · Ocrevus · Ozobax · QULIPTA · RADICAVA · REXULTI · RYTARY · Radicava · Rebif · SOLIRIS · Sunosi · TEGSEDI · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · VALTOCO · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAINUA · WAKIX · WATCHMAN · XCOPRI · XYWAV · Xadago · Xeomin
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Behavioral neurology & neuropsychiatry physicians in nearby ZIP areas
6
County median income
$111,521
Nearest hospital to ZIP centroid (approximate)
JEFFERSON ABINGTON HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Weisman is a mixed practice specialist, with above-average Medicare volume (top 17% in PA), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Weisman experienced with lecanemab injection, 1 mg?
Based on Medicare claims data, Dr. Weisman performed 78,700 lecanemab injection, 1 mg services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Weisman receive payments from pharmaceutical companies?
Yes. Dr. Weisman received a total of $178,789 from 67 companies across 456 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Weisman's costs compare to other behavioral neurology & neuropsychiatry physicians in Abington?
Dr. Weisman's average Medicare payment per service is $3. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Weisman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Behavioral Neurology & Neuropsychiatry Physicians in Abington
Browse behavioral neurology & neuropsychiatry physicians in Abington ranked by procedure volume and transparency data.
Highest volume
Top Behavioral Neurology & Neuropsychiatry Physicians in PA
Behavioral neurology & neuropsychiatry physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Behavioral Neurology & Neuropsychiatry Physicians in PA
Which PA behavioral neurology & neuropsychiatry physicians receive the most from drug and device companies.
By company
Eisai Inc. Payments to Doctors
See all physicians who received payments from Eisai Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology